Mahesh V. Patel - 03 Jan 2022 Form 4 Insider Report for Lipocine Inc. (LPCN)

Role
Chief Executive Officer, Director
Signature
/s/ Mahesh V. Patel
Issuer symbol
LPCN
Transactions as of
03 Jan 2022
Net transactions value
+$313,375
Form type
4
Filing time
03 Jan 2022, 16:33:10 UTC
Previous filing
08 Dec 2021
Next filing
16 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPCN Stock Option (Right to Buy) Award $313,375 +287,500 $1.09 287,500 03 Jan 2022 Common Stock 287,500 $1.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 3, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.